StockData
Creative Medical Technology Holdings, Inc. logo

Creative Medical Technology Holdings, Inc. (CELZ) stock

CELZNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 7/30
$0.48−0.04 (-8.36%)

Close on Nov 17, 2026Market cap $3.14MP/E –Yield –

Creative Medical Technology price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Creative Medical Technology's price to book ratio was 0.5× on Nov 11, 2026, against 1.2× a year earlier. Over the last 5 years it ranged from 0.4× to 24.2×, with a median of 0.8×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20260.5×−0.4
2025Dec 31, 20250.9×+0.4
2024Dec 31, 20240.5×−0.1
2023Dec 29, 20230.5×−1.9
2022Dec 30, 20222.4×–

More Creative Medical Technology figures

See a number that looks wrong?